Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Zolpidem improves task-specific dystonia : a randomized clinical trial integrating exploratory transcranial magnetic stimulation and [18F] FDG-PET imaging
Authors:ID Vogelnik Žakelj, Katarina (Author)
ID Trošt, Maja (Author)
ID Tomše, Petra (Author)
ID Petrović, Igor N. (Author)
ID Tomić Pešić, Aleksandra (Author)
ID Radovanović, Saša (Author)
ID Kojović, Maja (Author)
Files:.pdf PDF - Presentation file, download (3,15 MB)
MD5: CF936DCD5C15CD749A4CA465C17E7BC7
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background Task-specific dystonia (TSFD) is a disabling movement disorder. Effective treatment options are currently limited. Zolpidem was reported to improve primary focal and generalized dystonia in a proportion of patients. The mechanisms underlying its therapeutic effects have not yet been investigated. Methods We conducted a randomized, double-blind, placebo-controlled, crossover trial of single-dose zolpidem in 24 patients with TSFD. Patients were clinically assessed using Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS), Writers' Cramp Rating Scale (WCRS), and Visual Analogue Scale (VAS), before and after receiving placebo and zolpidem. Transcranial magnetic stimulation was conducted on placebo and zolpidem to compare corticospinal excitability – active and resting motor thresholds (AMT and RMT), resting and active input/output curves and intracortical excitability - cortical silent period (CSP), short-interval intracortical inhibition curve (SICI), long-interval intracortical inhibition (LICI) and intracortical facilitation (ICF). Eight patients underwent brain FDG-PET imaging on zolpidem and placebo. Results Zolpidem treatment improved TSFD. Zolpidem compared to placebo flattened rest and active input/output curves, reduced ICF and was associated with hypometabolism in the right cerebellum and hypermetabolism in the left inferior parietal lobule and left cingulum. Correlations were found between changes in dystonia severity on WCRS and changes in active input/output curve and in brain metabolism, respectively. Patients with lower RMT, and higher rest and active input/output curves exhibited better response to zolpidem compared to placebo. Conclusions Zolpidem improved TSFD by reducing corticomotor output and influencing crucial nodes in higher-order sensory and motor networks
Keywords:Zolpidem, writer's cramp, musician's dystonia, TMSFDG-PET
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 1-9
Numbering:Vol. 124
PID:20.500.12556/DiRROS-30117 New window
UDC:616.8
ISSN on article:1353-8020
DOI:10.1016/j.parkreldis.2024.107014 New window
COBISS.SI-ID:199949571 New window
Publication date in DiRROS:15.06.2026
Views:31
Downloads:12
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Parkinsonism & related disorders
Shortened title:Parkinsonism relat. disord.
Publisher:Elsevier Science
ISSN:1353-8020
COBISS.SI-ID:11416793 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-7310-2016
Name:NOVI CILJNI RECEPTORJI PRI DISTONIJI: ELEKTROFIZIOLOŠKI IN SLIKOVNI KORELATI UČINKA ZOLPIDEMA, SELEKTIVNEGA AGONISTA BENZODIAZEPINSKEGA PODTIPA RECEPTORJA ALFA-1, PRI RAZLIČNIH OBLIKAH PRIMARNE ŽARIŠČNE DISTONIJE

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back